San Diego-dependent Viking Therapeutics marked alone as a serious competitor in the weight loss drug sector in February immediately after revealing promising info from the mid-phase demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when provided for a weekly injection As well as in March the com